Cronos Group (CRON) Competitors C$3.81 +0.04 (+1.06%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock CRON vs. APHA, PBH, BHC, SLS, and AUPShould you buy Cronos Group stock or one of its competitors? MarketBeat compares Cronos Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cronos Group include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Solaris Resources (SLS), and Aurinia Pharmaceuticals (AUP). These companies are all part of the "pharmaceutical products" industry. CRON vs. APHACRON vs. PBHCRON vs. BHCCRON vs. SLSCRON vs. AUPHow does Cronos Group compare to Aphria?Cronos Group (TSE:CRON) and Aphria (TSE:APHA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk. Which has better valuation and earnings, CRON or APHA? Cronos Group has higher earnings, but lower revenue than Aphria. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$159.54M8.92-C$32.78MN/AN/AAphriaC$611.06M0.00-C$637.39M-C$2.01N/A Do analysts rate CRON or APHA? Cronos Group currently has a consensus target price of C$4.75, indicating a potential upside of 24.67%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Aphria.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer CRON or APHA? In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score. Company Overall Sentiment Cronos Group Neutral Aphria Neutral Is CRON or APHA more profitable? Aphria has a net margin of 0.00% compared to Cronos Group's net margin of -1.29%. Aphria's return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-1.29% -0.19% -3.73% Aphria N/A N/A N/A Do insiders & institutionals believe in CRON or APHA? 4.4% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryCronos Group beats Aphria on 6 of the 11 factors compared between the two stocks.How does Cronos Group compare to Premium Brands?Premium Brands (TSE:PBH) and Cronos Group (TSE:CRON) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment. Do insiders and institutionals have more ownership in PBH or CRON? 32.8% of Premium Brands shares are owned by institutional investors. Comparatively, 4.4% of Cronos Group shares are owned by institutional investors. 2.0% of Premium Brands shares are owned by insiders. Comparatively, 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to PBH or CRON? In the previous week, Premium Brands had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Premium Brands and 0 mentions for Cronos Group. Premium Brands' average media sentiment score of 0.45 beat Cronos Group's score of 0.00 indicating that Premium Brands is being referred to more favorably in the media. Company Overall Sentiment Premium Brands Neutral Cronos Group Neutral Which has preferable valuation & earnings, PBH or CRON? Premium Brands has higher revenue and earnings than Cronos Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPremium BrandsC$7.88B0.60C$99.56MC$0.90101.38Cronos GroupC$159.54M8.92-C$32.78MN/AN/A Is PBH or CRON more profitable? Premium Brands has a net margin of 0.52% compared to Cronos Group's net margin of -1.29%. Premium Brands' return on equity of 2.21% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Premium Brands0.52% 2.21% 3.61% Cronos Group -1.29%-0.19%-3.73% Which has more volatility and risk, PBH or CRON? Premium Brands has a beta of 0.801622, indicating that its stock price is 20% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.11805, indicating that its stock price is 12% more volatile than the broader market. Do analysts recommend PBH or CRON? Premium Brands currently has a consensus price target of C$118.62, indicating a potential upside of 30.00%. Cronos Group has a consensus price target of C$4.75, indicating a potential upside of 24.67%. Given Premium Brands' higher probable upside, analysts clearly believe Premium Brands is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.00Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryPremium Brands beats Cronos Group on 12 of the 15 factors compared between the two stocks.How does Cronos Group compare to Bausch Health Companies?Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership. Which has more volatility & risk, BHC or CRON? Bausch Health Companies has a beta of 0.631102, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.11805, meaning that its stock price is 12% more volatile than the broader market. Is BHC or CRON more profitable? Cronos Group has a net margin of -1.29% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Companies-13.54% 120.43% 4.16% Cronos Group -1.29%-0.19%-3.73% Which has preferable valuation & earnings, BHC or CRON? Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/ACronos GroupC$159.54M8.92-C$32.78MN/AN/A Do analysts recommend BHC or CRON? Cronos Group has a consensus price target of C$4.75, indicating a potential upside of 24.67%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in BHC or CRON? 10.0% of Bausch Health Companies shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor BHC or CRON? In the previous week, Bausch Health Companies had 12 more articles in the media than Cronos Group. MarketBeat recorded 12 mentions for Bausch Health Companies and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.25 indicating that Cronos Group is being referred to more favorably in the news media. Company Overall Sentiment Bausch Health Companies Neutral Cronos Group Neutral SummaryCronos Group beats Bausch Health Companies on 9 of the 15 factors compared between the two stocks.How does Cronos Group compare to Solaris Resources?Cronos Group (TSE:CRON) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk. Does the media prefer CRON or SLS? In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score. Company Overall Sentiment Cronos Group Neutral Solaris Resources Neutral Do analysts recommend CRON or SLS? Cronos Group currently has a consensus target price of C$4.75, indicating a potential upside of 24.67%. Solaris Resources has a consensus target price of C$19.50, indicating a potential upside of 39.89%. Given Solaris Resources' higher probable upside, analysts clearly believe Solaris Resources is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders have more ownership in CRON or SLS? 4.4% of Cronos Group shares are owned by institutional investors. Comparatively, 16.0% of Solaris Resources shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Comparatively, 40.6% of Solaris Resources shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better valuation and earnings, CRON or SLS? Cronos Group has higher revenue and earnings than Solaris Resources. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$159.54M8.92-C$32.78MN/AN/ASolaris ResourcesN/AN/A-C$46.49M-C$0.19N/A Which has more risk and volatility, CRON or SLS? Cronos Group has a beta of 1.11805, suggesting that its share price is 12% more volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.884686, suggesting that its share price is 88% more volatile than the broader market. Is CRON or SLS more profitable? Solaris Resources has a net margin of 0.00% compared to Cronos Group's net margin of -1.29%. Solaris Resources' return on equity of 60.97% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-1.29% -0.19% -3.73% Solaris Resources N/A 60.97%-51.67% SummarySolaris Resources beats Cronos Group on 6 of the 11 factors compared between the two stocks.How does Cronos Group compare to Aurinia Pharmaceuticals?Aurinia Pharmaceuticals (TSE:AUP) and Cronos Group (TSE:CRON) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment. Do analysts rate AUP or CRON? Cronos Group has a consensus price target of C$4.75, indicating a potential upside of 24.67%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Aurinia Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer AUP or CRON? In the previous week, Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score. Company Overall Sentiment Aurinia Pharmaceuticals Neutral Cronos Group Neutral Do institutionals & insiders have more ownership in AUP or CRON? 4.4% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is AUP or CRON more profitable? Aurinia Pharmaceuticals has a net margin of 0.00% compared to Cronos Group's net margin of -1.29%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Aurinia PharmaceuticalsN/A N/A N/A Cronos Group -1.29%-0.19%-3.73% Which has higher earnings and valuation, AUP or CRON? Cronos Group has higher revenue and earnings than Aurinia Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/ACronos GroupC$159.54M8.92-C$32.78MN/AN/A SummaryCronos Group beats Aurinia Pharmaceuticals on 7 of the 11 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition ExportMetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$1.42BC$2.22BC$6.45BC$12.16BDividend YieldN/A2.95%2.76%6.20%P/E Ratio-188.005.1621.2237.64Price / Sales8.921,770.59553.9211.68Price / Cash1.6710.1843.4982.29Price / Book1.2910.6110.374.50Net Income-C$32.78MC$20.70BC$3.57BC$299.09M7 Day Performance5.54%5.88%6.01%1.38%1 Month Performance4.67%3.71%3.52%1.46%1 Year Performance36.56%23.05%34.13%55.45% Cronos Group Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group2.4406 of 5 starsC$3.81+1.1%C$4.75+24.7%+35.1%C$1.42BC$159.54MN/A450APHAAphriaN/AN/AN/AN/AC$5.24BC$611.06MN/A1,200PBHPremium Brands3.5688 of 5 starsC$87.21+1.1%C$118.62+36.0%+12.2%C$4.53BC$7.88B96.90540BHCBausch Health Companies0.7284 of 5 starsC$7.49+3.7%N/A+23.4%C$2.80BC$10.53BN/A19,900SLSSolaris Resources1.5077 of 5 starsC$14.65-4.2%C$19.50+33.1%+113.8%C$2.45BN/AN/A10 Related Companies and Tools Related Companies Aphria Alternatives Premium Brands Alternatives Bausch Health Companies Alternatives Solaris Resources Alternatives Aurinia Pharmaceuticals Alternatives Cara Operations Alternatives International Tower Hill Mines Alternatives Tilray Brands Alternatives Tervita Alternatives Noront Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRON) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
